Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
30
CSLLY Quote, Financials, Valuation and Earnings
Last price:
$58.19
Seasonality move
:
4.85%
Day range:
$57.89 - $59.14
52-week range:
$54.10 - $90.04
Dividend yield:
2.51%
P/E ratio:
18.84x
P/S ratio:
3.67x
P/B ratio:
4.51x
Volume:
56.3K
Avg. volume:
158.9K
1-year change:
-34.46%
Market cap:
$56.3B
Revenue:
$15.4B
EPS (TTM):
$1.05
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, CSL Ltd. has -- downside to fair value with a price target of -- per share.
CSLLY vs. S&P 500
-
Over the past 5 trading days, CSL Ltd. has overperformed the S&P 500 by 0.21% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CSL Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CSL Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter CSL Ltd. reported revenues of $8.2B.
Earnings Growth
-
CSL Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter CSL Ltd. reported earnings per share of $2.07.
Enterprise value:
96.2B
EV / Invested capital:
--
Price / LTM sales:
3.67x
EV / EBIT:
24.90x
EV / Revenue:
6.43x
PEG ratio (5yr expected):
0.57x
EV / Free cash flow:
-337.91x
Price / Operating cash flow:
22.07x
Enterprise value / EBITDA:
19.96x
Gross Profit (TTM):
$7.5B
Return On Assets:
7.11%
Net Income Margin (TTM):
20.32%
Return On Equity:
14.06%
Return On Invested Capital:
8.85%
Operating Margin:
24.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $11.7B | $14B | $15.1B | -- | $8.2B | |
| Gross Profit | $5.9B | $6.8B | $7.3B | -- | $4.3B | |
| Operating Income | $2.8B | $3.4B | $3.8B | -- | $2B | |
| EBITDA | $3.4B | $4.3B | $4.8B | -- | $3.2B | |
| Diluted EPS | $2.18 | $2.58 | $2.82 | -- | $2.07 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.4B | $16.5B | $9.3B | $10.8B | -- | |
| Total Assets | $18.2B | $28.3B | $36.2B | $38B | -- | |
| Current Liabilities | $3.1B | $7.1B | $4.6B | $5B | -- | |
| Total Liabilities | $9.8B | $13.8B | $18.4B | $18.6B | -- | |
| Total Equity | $8.4B | $14.6B | $17.8B | $19.4B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 1996-09-30 | 1997-09-30 | 1998-09-30 | 1997-09-30 | 1998-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $398M | $303M | |
| Cash From Investing | -- | -- | -- | -$169M | $282M | |
| Cash From Financing | -- | -- | -- | -$237M | -$547M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CSLLY
Sector
Market Cap
$56.3B
$28M
Price % of 52-Week High
64.61%
51.03%
Dividend Yield
2.51%
0%
Shareholder Yield
1.71%
-1.54%
1-Year Price Total Return
-34.46%
-17.48%
Beta (5-Year)
0.768
0.518
Dividend yield:
2.51%
Annualized payout:
$1.38
Payout ratio:
-42.55%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$58.57
200-day SMA
Sell
Level
$73.06
Bollinger Bands (100)
Sell
Level
57.99 - 74.87
Chaikin Money Flow
Buy
Level
18.7M
20-day SMA
Sell
Level
$59.85
Relative Strength Index (RSI14)
Sell
Level
42.45
ADX Line
Sell
Level
16.2
Williams %R
Neutral
Level
-61.3847
50-day SMA
Sell
Level
$61.06
MACD (12, 26)
Sell
Level
-0.61
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
4.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1297)
Buy
CA Score
(Annual)
Level (0.0398)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.0661)
Buy
Piotroski F Score
(Annual)
Level (9)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Stock Forecast FAQ
In the current month, CSLLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CSLLY average analyst price target in the past 3 months is --.
-
Where Will CSL Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CSL Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About CSL Ltd.?
Analysts are divided on their view about CSL Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CSL Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is CSL Ltd.'s Price Target?
The price target for CSL Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CSLLY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CSL Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CSLLY?
You can purchase shares of CSL Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CSL Ltd. shares.
-
What Is The CSL Ltd. Share Price Today?
CSL Ltd. was last trading at $58.19 per share. This represents the most recent stock quote for CSL Ltd.. Yesterday, CSL Ltd. closed at $58.17 per share.
-
How To Buy CSL Ltd. Stock Online?
In order to purchase CSL Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CSLLY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CSLLY
Sector
P/E ratio
18.84x
23.89x
PEG ratio
0.57x
-0.01x
P/B ratio
4.51x
1.82x
Price / LTM sales
3.67x
1.60x
Growth Metrics
CSLLY
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.88%
Revenue (5-year growth)
11.12%
6.5%
Earnings forecast
--
-$0.21
Profitability
CSLLY
Sector
Profitability FY 2025
$7.5B
$3.5M
Return on invested capital
8.85%
-31.77%
Return on assets
7.11%
-27.96%
Return on equity
14.06%
-37.63%
Earnings Date
Last Earnings Date
Aug
18
Next Earnings Date
Feb
10
Estimated Next Earnings Date
Nov
17
Balance Sheet
CSLLY
Sector
Total cash
$1.5B
$26.3M
Short term investments
--
$25.7M
Total assets
$39.4B
$78M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
